4.5 Article

Prognostic factors of 30-day mortality in patients with COVID-19 pneumonia under standard remdesivir and dexamethasone treatment

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

Risk factors for COVID-19 progression and mortality in hospitalized patients without pre-existing comorbidities

Weifang Liu et al.

Summary: COVID-19 patients without chronic comorbidities have specific clinical characteristics and risk factors associated with disease progression and death. Factors including age, oxygen saturation, certain laboratory parameters, and symptoms like dyspnea are closely related to COVID-19 prognosis in this specific patient population.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2022)

Article Immunology

Reduced Vitamin K Status as a Potentially Modifiable Risk Factor of Severe Coronavirus Disease 2019

Anton S. M. Dofferhoff et al.

Summary: The study found significantly elevated levels of dp-ucMGP in COVID-19 patients, indicating extrahepatic vitamin K insufficiency that was associated with poor outcomes. Hepatic procoagulant factor II levels remained normal, suggesting pneumonia-induced extrahepatic vitamin K depletion in COVID-19 patients leading to accelerated elastic fiber damage and thrombosis.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Recommendations for antibacterial therapy in adults with COVID-19-an evidence based guideline

Elske Sieswerda et al.

Summary: The Dutch Working Party on Antibiotic Policy formed a multidisciplinary expert committee to provide evidence-based recommendations for antibacterial therapy in hospitalized adults with COVID-19. The committee suggested restrictive antibiotic use upon admission and outlined specific criteria for stopping antibiotic treatment. The study emphasized the importance of laboratory tests in guiding antibiotic therapy.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Review Virology

Predictors ofCOVID-19 severity: A literature review

Benjamin Gallo Marin et al.

Summary: The severity and mortality of COVID-19 may be associated with patient age, multiple comorbidities, hypoxia, extensive lung involvement on CT scans, laboratory abnormalities, and biomarkers of end-organ dysfunction.

REVIEWS IN MEDICAL VIROLOGY (2021)

Article Medicine, General & Internal

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity

Mark W. Tenforde et al.

Summary: This study evaluated the association between mRNA COVID-19 vaccines and COVID-19 hospitalization, as well as disease progression to critical illness among hospitalized patients. The results showed that vaccination with mRNA COVID-19 vaccines significantly decreased the likelihood of COVID-19 hospitalization and disease progression to death or mechanical ventilation.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Oncology

Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study

Jongmin Lee et al.

Summary: This study from a Korean nationwide cohort suggests that lymphopenia and its severity levels can serve as reliable predictive factors for COVID-19 clinical outcomes, including mortality, need for intensive care, and oxygen requirements. Lymphopenia at the initial presentation of COVID-19 is associated with poor prognosis, and the intensity of lymphopenia is independently associated with higher COVID-19 mortality.

CANCERS (2021)

Article Geriatrics & Gerontology

Hypercalcemia as a Biomarker of Poor Prognosis in Frail Elderly Patients with COVID-19

D. Pamart et al.

Summary: This cohort study aimed to investigate the association between hypercalcemia in early COVID-19 and 3-month mortality in frail elderly patients. The results showed that hypercalcemia was associated with a higher mortality rate in this population.

JOURNAL OF NUTRITION HEALTH & AGING (2021)

Article Public, Environmental & Occupational Health

The role of C-reactive protein as a prognostic marker in COVID-19

Dominic Stringer et al.

Summary: The study found that a threshold of CRP >= 40 mg/L on admission is a good indicator for predicting inpatient mortality in COVID-19 patients. This threshold can assist clinicians in early assessment of patient severity, treatment decisions, and further care planning.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2021)

Article Medicine, General & Internal

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

Jamie Lopez Bernal et al.

Summary: This study estimated the real-world effectiveness of Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed COVID-19 symptoms, hospital admissions, and deaths. The vaccines showed significant reduction in symptomatic COVID-19 among older adults and further protection against severe disease. Both vaccines demonstrated similar effects and protection was maintained for over 6 weeks.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Infectious Diseases

Prognostic Role of Anemia in COVID-19 Patients: A Meta-Analysis

Marco Zuin et al.

Summary: A systematic review and meta-analysis found that approximately 25.6% of COVID-19 patients have anemia, which is significantly associated with a higher short-term mortality risk. This association is particularly influenced by factors such as age and chronic kidney disease.

INFECTIOUS DISEASE REPORTS (2021)

Article Multidisciplinary Sciences

D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19

Ayusha Poudel et al.

Summary: This study found that admission D-dimer value is an accurate biomarker for predicting mortality in patients with COVID-19, with an optimal cutoff value of 1.5 mu g/ml.

PLOS ONE (2021)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Public, Environmental & Occupational Health

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Cardiac & Cardiovascular Systems

Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection

Dominik Rath et al.

CLINICAL RESEARCH IN CARDIOLOGY (2020)

Article Medical Laboratory Technology

Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients

Erika Poggiali et al.

CLINICA CHIMICA ACTA (2020)

Review Public, Environmental & Occupational Health

Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis

Petek Eylul Taneri et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)

Article Nutrition & Dietetics

Prevalence and severity of malnutrition in hospitalized COVID-19 patients

Dorothee Bedock et al.

CLINICAL NUTRITION ESPEN (2020)

Review Endocrinology & Metabolism

Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis

R. A. Tuty Kuswardhani et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Article Emergency Medicine

Red cell distribution width is a prognostic factor in severe sepsis and septic shock

You Hwan Jo et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2013)

Article Critical Care Medicine

Red cell distribution width and all-cause mortality in critically ill patients

Heidi S. Bazick et al.

CRITICAL CARE MEDICINE (2011)

Article Critical Care Medicine

ViEWS-Towards a national early warning score for detecting adult inpatient deterioration

David R. Prytherch et al.

RESUSCITATION (2010)

Article Medicine, General & Internal

Red Blood Cell Distribution Width and Mortality Risk in a Community-Based Prospective Cohort

Todd S. Perlstein et al.

ARCHIVES OF INTERNAL MEDICINE (2009)